| P50 | author | Gen Sobue | Q67219868 |
| | Hideyuki Takeuchi | Q87350460 |
| | Koji Yamanaka | Q37377501 |
| | Mariko Noda | Q42177315 |
| P2093 | author name string | Yan Zhou | |
| | Hua Li | |
| | Jun Sato | |
| | Hiroyuki Mizoguchi | |
| | Rarami Mori | |
| | Akio Suzumura | |
| | Jun Kawanokuchi | |
| | Shijie Jin | |
| | Tetsuya Mizuno | |
| | Bijay Parajuli | |
| | Yoshifumi Sonobe | |
| | Yukiko Doi | |
| | Endong Li | |
| | Jianfeng Liang | |
| | Satoko Yasuoka | |
| P2860 | cites work | Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor | Q24306745 |
| | Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease | Q24621854 |
| | Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model | Q24631645 |
| | Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo | Q28131779 |
| | Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons | Q28298056 |
| | Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine | Q29465775 |
| | Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation | Q29547561 |
| | Microglia-mediated neurotoxicity: uncovering the molecular mechanisms | Q29547835 |
| | Unraveling the mechanisms involved in motor neuron degeneration in ALS | Q29619073 |
| | Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis | Q29619430 |
| | Onset and progression in inherited ALS determined by motor neurons and microglia | Q29619515 |
| | Gating and regulation of connexin 43 (Cx43) hemichannels | Q30480722 |
| | Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease | Q30491484 |
| | Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. | Q31832269 |
| | Newer aspects of glutamine/glutamate metabolism: the role of acute pH changes | Q33749201 |
| | Gap junctions, synchrony and seizures | Q33826762 |
| | Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model | Q48251811 |
| | Accumulation of phosphorylated alpha-synuclein in aging human brain | Q48266774 |
| | Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines | Q48440751 |
| | Astrocytic gap junctions remain open during ischemic conditions. | Q48493362 |
| | Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke | Q48577890 |
| | Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins | Q48601563 |
| | Amyotrophic lateral sclerosis with numerous axonal spheroids in the corticospinal tract and massive degeneration of the cortex | Q48629386 |
| | Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner. | Q53278044 |
| | Neurofibrillary axonal swellings and amyotrophic lateral sclerosis | Q70790611 |
| | Microglia rules: insights into microglial-neuronal signaling | Q80547750 |
| | A strategy for developing effective amyotropic lateral sclerosis pharmacotherapy: from clinical trials to novel pharmacotherapeutic strategies | Q94704277 |
| | Targeting drugs to the brain by redox chemical delivery systems. | Q33996838 |
| | Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse | Q34007194 |
| | Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. | Q34417339 |
| | Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial | Q34798154 |
| | Inflammatory processes in amyotrophic lateral sclerosis | Q34936474 |
| | Microglia in diseases of the central nervous system | Q35054979 |
| | Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-gamma and tumor necrosis factor-alpha | Q35059879 |
| | Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial | Q35809317 |
| | Gap junctional communication in tissue inflammation and repair. | Q36162602 |
| | MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon | Q36431988 |
| | Roles of glia-derived cytokines on neuronal degeneration and regeneration | Q36693990 |
| | Properties of gap junction blockers and their behavioural, cognitive and electrophysiological effects: animal and human studies | Q37375210 |
| | Pre-symptomatic detection of chronic motor deficits and genotype prediction in congenic B6.SOD1(G93A) ALS mouse model. | Q37440150 |
| | Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia | Q37569879 |
| | The gap junction proteome and its relationship to disease | Q37640469 |
| | Motor neuron disease: systematic reviews of treatment for ALS and SMA. | Q37656842 |
| | 17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration | Q40374915 |
| | Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism. | Q40496060 |
| | Glia-neuron intercommunications and synaptic plasticity | Q41173085 |
| | The proposed role of glutamine in some cells of the immune system and speculative consequences for the whole animal | Q41570307 |
| | Brain metabolism of branched-chain amino acids | Q41595192 |
| | Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture | Q41967685 |
| | Synergistic effects of long-term antioxidant diet and behavioral enrichment on beta-amyloid load and non-amyloidogenic processing in aged canines | Q42148708 |
| | Astrocytic gap junction blockage and neuronal Ca2+ oscillation in neuron-astrocyte cocultures in vitro | Q42459376 |
| | Functional and morphological changes induced by transient in vivo ischemia | Q42492866 |
| | Ischemia-induced brain damage depends on specific gap-junctional coupling | Q43937493 |
| | Alzheimer's amyloid beta-peptide enhances ATP/gap junction-mediated calcium-wave propagation in astrocytes | Q44497733 |
| | Neuroscience. Microglia: the enemy within? | Q44681258 |
| | Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport | Q45216891 |
| | Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice | Q46124391 |
| | Blockade of microglial glutamate release protects against ischemic brain injury | Q46385482 |
| | Macrophage-induced neurotoxicity is mediated by glutamate and attenuated by glutaminase inhibitors and gap junction inhibitors | Q46614579 |
| | Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity | Q46645810 |
| | Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. | Q46733868 |
| | Interferon-beta is neuroprotective against the toxicity induced by activated microglia | Q46974690 |
| | The effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective. | Q48228480 |
| | Neurochemical diversity of dystrophic neurites in the early and late stages of Alzheimer's disease. | Q48245330 |
| | Reduction of methamphetamine-induced sensitization and reward in matrix metalloproteinase-2 and -9-deficient mice | Q48248931 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | e21108 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease | |
| P478 | volume | 6 | |